Skip to content
Clinical Research Society

Clinical Research Society

International Society for Clinical Research and Translational Medicine

  • About Us
    • Executive Council
    • Committees
    • President’s Message
    • Code of Ethics
    • Our Logo
  • Membership
    • Professional Membership
    • Associate Membership
    • Student Membership
    • Institutional Membership
    • Membership Renewal
  • Training & Certification
    • GCP Certification
    • CRA Certification
    • CRC Certification
    • Emerging Clinical Research Professional
    • Project Management Certification
    • Training Demo
    • Register for Certification Exam
  • Careers
  • Contact

Novartis

Clinical Research / Pharma News 

Recent Studies Indicate Eltrombopag is Well Tolerated and Effective

FDA and EU approved treatment for ITP, immune thrombocytopenia treatment, Novartis

The outcomes of two global studies performed at many trial centers globally demonstrate in a first that eltrombopag is a

Read more
Clinical Research / Pharma News 

Novartis Entresto One Step Closer To European Commission Approval

EU approval, Novartis, us fda

Novartis ($NVS) has recently suggested that its kick off of recently US FDA accepted heart failure medicine Entresto will be

Read more
Clinical Research / Pharma News 

Novartis Entresto Gets Approval from US FDA

LCZ696, Novartis, us fda

Switzerland based leading global pharmaceutical company Novartis has obtained approval from the US Food and Drug Administration (FDA) for its

Read more
Clinical Research / Pharma News 

Roche Continues to be at the Top in Oncology Sales

Novartis, Oncology sales in 2014, Top cancer drugs

Swiss drug maker Roche continues to be at the top of the heap in oncology sales for several years and

Read more
Clinical Research / Pharma News 

Novartis’s Investigational Drug LCZ696 is More Effective than ACE Inhibitors for Treating CHF

ACE inhibitors, Novartis, Treatments available for Chronic Heart Failure

For treating individuals with chronic heart failure (CHF), ACE (angiotensin-converting enzyme) inhibitors are generally the first choice. But a new

Read more

Example Widget

This is an example widget to show how the Right Sidebar looks by default. You can add custom widgets from the widgets screen in the admin. If custom widgets are added then this will be replaced by those widgets.

Copyright © 2022 Clinical Research Society. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.

Offer the visitors your services or goods.

Describe what they will receive and how they will benefit from it.

Do not forget a coaxing call to action, but also a way to decline.
Put the final call to action.

  • Yes I want it!
  • No thank you!